Page last updated: 2024-10-24

camostat and Carcinoma, Squamous Cell

camostat has been researched along with Carcinoma, Squamous Cell in 7 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" This drug at a dosage of 10 mg/kg or 20 mg/kg was administered by ip injection to 20 mice each harboring a solitary tumor twice daily for 10 weeks."1.26Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate. ( Ohkoshi, M, 1981)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Sun, G1
Sui, Y1
Zhou, Y1
Ya, J1
Yuan, C1
Jiang, L1
Huang, M1
Ohkoshi, M6
Fujii, S3
Oka, T1

Reviews

1 review available for camostat and Carcinoma, Squamous Cell

ArticleYear
[Protease inhibitors as anticancer chemotherapy--experimental and clinical studies].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Carcinoma, Squamous Cell; Cell Division; Colonic Neo

1995

Other Studies

6 other studies available for camostat and Carcinoma, Squamous Cell

ArticleYear
Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat.
    Journal of virology, 2021, 09-09, Volume: 95, Issue:19

    Topics: Antiviral Agents; Carcinoma, Squamous Cell; COVID-19; COVID-19 Drug Treatment; Esters; Guanidines; H

2021
Effect of a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of mouse skin carcinoma in the rapid growing stage.
    The Journal of dermatology, 1984, Volume: 11, Issue:1

    Topics: Administration, Oral; Animals; Carcinoma, Squamous Cell; Cell Division; Esters; Female; Gabexate; Gu

1984
Effect of the synthetic protease inhibitor [N,N-dimethylcarbamoyl-methyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on carcinogenesis by 3-methylcholanthrene in mouse skin.
    Journal of the National Cancer Institute, 1983, Volume: 71, Issue:5

    Topics: Animals; Carcinoma, Squamous Cell; Diet; Esters; Female; Gabexate; Guanidines; Methylcholanthrene; M

1983
Clinical experience with a protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate for prevention of recurrence of carcinoma of the mouth and in treatment of terminal carcinoma.
    Journal of maxillofacial surgery, 1984, Volume: 12, Issue:4

    Topics: Adult; Carcinoma, Squamous Cell; Esters; Evaluation Studies as Topic; Female; Gabexate; Guanidines;

1984
Effect of oral administration of protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate on the growth of 3-methylcholanthrene-induced carcinoma in mice.
    Gan, 1982, Volume: 73, Issue:1

    Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Esters; Female; Gabexate; Guanidines; Methylcholan

1982
Inhibition of growth of 3-methylcholanthrene-induced mouse skin tumor by protease inhibitor [N,N-dimethylcarbamoylmethyl 4-(4-guanidinobenzoyloxy)-phenylacetate] methanesulfate.
    Gan, 1981, Volume: 72, Issue:6

    Topics: Animals; Body Weight; Carcinoma, Squamous Cell; Cell Division; Drug Evaluation, Preclinical; Esters;

1981